Literature DB >> 23205094

Effect of mesenchymal stem cells on hypoxia-induced desensitization of β2-adrenergic receptors in rat osteosarcoma cells.

Akira Kido1, Kazuhiro Yoshitani, Takamasa Shimizu, Manabu Akahane, Hiromasa Fujii, Shinji Tsukamoto, Yumiko Kondo, Kanya Honoki, Motohiro Imano, Yasuhito Tanaka.   

Abstract

The β2-adrenergic receptor (β2AR) mediates the effects of chronic stress in several neoplasms, however, β2AR signaling is impaired by hypoxia in various tissues. While hypoxia is a common feature significant in the progression of solid tumors, little is known about the effect of hypoxia on β2AR signaling in the tumor microenvironment. Previously, it has been reported that the systemic administration of mesenchymal stem cells (MSCs) increased the engraftment and metastatic colonization of rat osteosarcoma (OS) cells. In the current study, the effect of MSCs on the hypoxia-induced desensitization of the β2AR in OS cells was investigated. Epinephrine, norepinephrine and isoproterenol increased the cellular proliferation of the rat OS cell line COS1NR and rat MSCs in a dose-dependent and β2AR antagonist-sensitive manner. While isoproterenol had significant proliferative effects on MSCs under normoxic and hypoxic conditions, COS1NR cells did not respond under hypoxic conditions. A sensitivity assay for the β2AR revealed that hypoxia impaired the sensitivity of COS1NR cells, whereas hypoxia did not affect MSCs. An immunoassay revealed no significant change in the expression of hypoxia-inducible factor-1α (HIF1α) in COS1NR cells, whilst an immunoassay demonstrated a 15% increase in MSCs following isoproterenol stimulation. In COS1NR cells co-cultured with MSCs under hypoxic conditions, isoproterenol caused a significant increase in proliferation and this effect was inhibited by an anti-interleukin (IL)-6 antibody. A tumor formation assay in syngeneic rats revealed that the systemic administration of MSCs enhances the growth of OS and the effect of MSCs was inhibited by IL-6 neutralization. In conclusion, MSCs are resistant to the hypoxia-induced desensitization to β2AR. Hypoxia caused a siginificant desensitization of the β2AR in COS1NR cells alone, whereas MSCs may support tumor progression through cellular interactions.

Entities:  

Year:  2012        PMID: 23205094      PMCID: PMC3506631          DOI: 10.3892/ol.2012.813

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  26 in total

1.  Impaired G(s)alpha and adenylyl cyclase cause beta-adrenoceptor desensitization in chronically hypoxic rat hearts.

Authors:  J M Pei; X C Yu; M L Fung; J J Zhou; C S Cheung; N S Wong; M P Leung; T M Wong
Journal:  Am J Physiol Cell Physiol       Date:  2000-11       Impact factor: 4.249

2.  Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.

Authors:  Jan C Brune; Ariane Tormin; Maria C Johansson; Pehr Rissler; Otte Brosjö; Richard Löfvenberg; Fredrik Vult von Steyern; Fredrik Mertens; Anders Rydholm; Stefan Scheding
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

3.  In vitro bone formation by rat marrow cell culture.

Authors:  H Ohgushi; Y Dohi; T Katuda; S Tamai; S Tabata; Y Suwa
Journal:  J Biomed Mater Res       Date:  1996-11

4.  Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.

Authors:  Shinji Tsukamoto; Kanya Honoki; Hiromasa Fujii; Yasuaki Tohma; Akira Kido; Toshio Mori; Toshifumi Tsujiuchi; Yasuhito Tanaka
Journal:  Int J Oncol       Date:  2011-10-03       Impact factor: 5.650

5.  Effects of 5-day hypoxia on cardiac adrenergic neurotransmission in rats.

Authors:  K Mardon; P Merlet; A Syrota; B Mazière
Journal:  J Appl Physiol (1985)       Date:  1998-09

6.  Cancer biology. All in the stroma: cancer's Cosa Nostra.

Authors:  Jean Marx
Journal:  Science       Date:  2008-04-04       Impact factor: 47.728

7.  Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.

Authors:  Susan K Lutgendorf; Steven Cole; Erin Costanzo; Sarah Bradley; Jeremy Coffin; Sarvenaz Jabbari; Kaitlin Rainwater; Justine M Ritchie; Maria Yang; Anil K Sood
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

8.  Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.

Authors:  Alexander B Mohseny; Karoly Szuhai; Salvatore Romeo; Emilie P Buddingh; Inge Briaire-de Bruijn; Daniëlle de Jong; Melissa van Pel; Anne-Marie Cleton-Jansen; Pancras C W Hogendoorn
Journal:  J Pathol       Date:  2009-11       Impact factor: 7.996

9.  Osteogenic matrix sheet-cell transplantation using osteoblastic cell sheet resulted in bone formation without scaffold at an ectopic site.

Authors:  Manabu Akahane; Akifumi Nakamura; Hajime Ohgushi; Hideki Shigematsu; Yoshiko Dohi; Yoshinori Takakura
Journal:  J Tissue Eng Regen Med       Date:  2008-06       Impact factor: 3.963

10.  Functional alpha1- and beta2-adrenergic receptors in human osteoblasts.

Authors:  H H Huang; T C Brennan; M M Muir; R S Mason
Journal:  J Cell Physiol       Date:  2009-07       Impact factor: 6.384

View more
  3 in total

Review 1.  Bone microenvironment signals in osteosarcoma development.

Authors:  Arantzazu Alfranca; Lucia Martinez-Cruzado; Juan Tornin; Ander Abarrategi; Teresa Amaral; Enrique de Alava; Pablo Menendez; Javier Garcia-Castro; Rene Rodriguez
Journal:  Cell Mol Life Sci       Date:  2015-05-03       Impact factor: 9.261

2.  MAGED2 Is Required under Hypoxia for cAMP Signaling by Inhibiting MDM2-Dependent Endocytosis of G-Alpha-S.

Authors:  Elie Seaayfan; Sadiq Nasrah; Lea Quell; Maja Kleim; Stefanie Weber; Hemmo Meyer; Kamel Laghmani; Martin Kömhoff
Journal:  Cells       Date:  2022-08-16       Impact factor: 7.666

3.  Norepinephrine Inhibits the Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells via β2-Adrenoceptor-Mediated ERK1/2 and PKA Phosphorylation.

Authors:  Jessica Hedderich; Karima El Bagdadi; Peter Angele; Susanne Grässel; Andrea Meurer; Rainer H Straub; Frank Zaucke; Zsuzsa Jenei-Lanzl
Journal:  Int J Mol Sci       Date:  2020-05-30       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.